Adjuvant Chemoradiotherapy With Epirubicin, Cisplatin, and Fluorouracil Compared With Adjuvant Chemoradiotherapy With Fluorouracil and Leucovorin After Curative Resection of Gastric Cancer: Results From CALGB 80101 (Alliance)
Charles S. Fuchs(University of Southern California), Robert J. Mayer(Applied Natural Sciences), Christopher G. Willett, Joel E. Tepper(University of North Carolina at Chapel Hill), Steven R. Alberts(North Central Cancer Treatment Group), Jeffrey A. Meyerhardt(CancerCare), David H. Ilson(Memorial Sloan Kettering Cancer Center), Alan P. Venook(University of California, San Francisco), Kristen K. Ciombor(Vanderbilt University Medical Center), Georg A. Bjarnason(Sunnybrook Health Science Centre), Tomislav Dragovich(The University of Texas MD Anderson Cancer Center), Donna Niedzwiecki(Duke University), Eileen M. O’Reilly(Memorial Sloan Kettering Cancer Center), Leonard L. Gunderson(Mayo Clinic in Arizona), Richard M. Goldberg(Ontario Institute for Cancer Research), Harvey J. Mamon(Brigham and Women's Hospital), David Van Den Berg(University of Southern California), Peter C. Enzinger(Dana-Farber Cancer Institute), Daniel G. Haller(University of Pennsylvania), Xing Ye(Dana-Farber Brigham Cancer Center), Richard S. Swanson(Brigham and Women's Hospital)
Cited by 137
Related Papers
PD-1 Blockade in Tumors with Mismatch-Repair Deficiency
|New England Journal of Medicine|2015|9.4k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.6k
The landscape of somatic copy-number alteration across human cancers
|Nature|2010|4.1k
Fusobacterium nucleatum Potentiates Intestinal Tumorigenesis and Modulates the Tumor-Immune Microenvironment
|Cell Host & Microbe|2013|2.7k